At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
Remifentanil 1 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Target-controlled Infusion of Remifentanil for Laryngeal Mask Airway Insertion During Sevoflurane Induction in Adults
In Brief
A clinical study evaluating Remifentanil 1, Control, and 1 other intervention for Laryngismus. Completed, enrolled 102 participants across 1 site.
Detailed Summary
The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaryngismus
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedOct 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedOct 20, 2011
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.7 years ago
Interventions
Remifentanil 1drug
"Remifentanil 1": "The R1 group, which received a target effect-site remifentanil concentration of 1 ng/ml.
Controldrug
The control group, which received an infusion of normal saline
Remifentanil 2drug
"Remifentanil 2": "The R2group, which received a target effect-site remifentanil concentration of 2 ng/ml.